EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy

Alzheimer's disease (AD) is a typical neurodegenerative disease that leads to irreversible neuronal degeneration, and effective treatment remains elusive due to the unclear mechanism. We utilized biocompatible mesenchymal stem cell-derived extracellular vesicles as carriers loaded with the CB2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yanjing, Huang, Ruiqi, Wang, Deheng, Yu, Liqun, Liu, Yuchen, Huang, Runzhi, Yin, Shuai, He, Xiaolie, Chen, Bairu, Liu, Zhibo, Cheng, Liming, Zhu, Rongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2023
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460952/
https://www.ncbi.nlm.nih.gov/pubmed/37645682
http://dx.doi.org/10.1016/j.ajps.2023.100835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460952/
https://www.ncbi.nlm.nih.gov/pubmed/37645682
http://dx.doi.org/10.1016/j.ajps.2023.100835

Ejemplares similares